Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07203768 · ClinicalTrials.gov registry record

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

A clinical trial of Polycythemia Vera and Thrombocythemia, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS.

Recruiting
Registry status
678
Enrollment target
20
Study locations

NCT07203768 is a study of Polycythemia Vera and Thrombocythemia that is actively recruiting participants, run by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS. The registered enrollment target is 678 participants, above the 310-participant average among 22 other Polycythemia Vera trials with a reported enrollment target (119% higher). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07203768, a study of Polycythemia Vera and Thrombocythemia, is actively recruiting participants, sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS.

RECRUITING
Registry status
678 participants
Enrollment target
20
Study locations

Study Summary

International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).

Conditions Studied

Polycythemia Vera Thrombocythemia

Study Locations (20)

Other

  • University Hospital Halle - Halle
  • Hannover Medical School - Hanover
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center - Minden
  • A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia - Alessandria
  • ASST Papa Giovanni XXIII, SC Ematologia - Bergamo
  • ASST-Spedali Civili - Brescia
  • Ospedale Businco - Cagliari
  • AOU Policlinico Vittorio Emanuele - PO Gaspare Rodolico - Catania
  • AOU Careggi, Divisione di Ematologia - Florence
  • ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia - Milan
  • Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico - Milan
  • Ospedale San Raffaele - Milan
  • ASST MONZA Ospedale San Gerardo Clinica Ematologica - Monza
  • Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo - Naples
  • Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia - Novara
  • Presidio Ospedaliero di Pescara - Pescara
  • Fondazione Policlinico Universitario Gemelli - Roma

Minnesota

  • Mayo Clinic - Rochester

Lombardy

  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo - Pavia

Veneto

  • Divisione Ematologia, Ospedale San Bortolo - Vicenza

Trial Details

FieldValue
Enrollment Target 678 participants
Start Date 2025-12-01
Est. Completion 2026-07-31

Sponsor

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07203768

The ClinicalTrials.gov registry entry for NCT07203768 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 310-participant average among 22 other Polycythemia Vera trials with a reported enrollment target (119% higher). The listed sponsor is FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Polycythemia Vera appearing as the primary indexed condition, and to 0 interventions.

NCT07203768 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Other, Minnesota, Lombardy.

Frequently Asked Questions

What is clinical trial NCT07203768 about?

NCT07203768 is a clinical study titled "A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes". International multicenter retrospective observational study consisting of two parts: a nested case-control study (part A) and a comparative retrospective cohort study (part B).

What is the current status of trial NCT07203768?

This trial is currently recruiting. The enrollment target is 678 participants. The study started on 2025-12-01. Estimated completion is 2026-07-31.

What conditions does trial NCT07203768 study?

This clinical trial studies the following conditions: Polycythemia Vera, Thrombocythemia.

Who is sponsoring clinical trial NCT07203768?

This trial is sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07203768 being conducted?

This trial has 20 study locations across Minnesota, Lombardy, Veneto. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Polycythemia Vera

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Polycythemia Vera

All registered trials for this condition

Thrombocythemia

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.